PMID
Cmpds
Data
Article Title
Organization
5
Furanoterpenes, new types of protein tyrosine phosphatase 1B inhibitors, from two Indonesian marine sponges, Ircinia and Spongia spp.

Tohoku Medical and Pharmaceutical University
4
Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors.

Indiana University School of Medicine
11
Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.

Sanford-Burnham Medical Research Institute
9
A potent and selective inhibitor for the UBLCP1 proteasome phosphatase.

Indiana University
39
Therapeutic potential of targeting the oncogenic SHP2 phosphatase.

Indiana University School of Medicine
23
Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening.

Shandong University
13
RE12 derivatives displaying Vaccinia H1-related phosphatase (VHR) inhibition in the presence of detergent and their anti-proliferative activity against HeLa cells.

Japan Science and Technology Agency
30
A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases.

Indiana University School of Medicine
4
Design, synthesis and insulin-sensitising effects of novel PTP1B inhibitors.

Peking Union Medical College
18
Discovery and evaluation of novel inhibitors of mycobacterium protein tyrosine phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic acid scaffold.

Indiana University School of Medicine
26
Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.

University of Paris
20
Dual-Specificity Phosphatase CDC25A/B Inhibitor Identified from a Focused Library with Nonelectrophilic Core Structure.

TBA
2
Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.

Imperial College
10
Identification and characterization of novel inhibitors of mPTPB, an essential virulent phosphatase from Mycobacterium tuberculosis.

Indiana University School of Medicine
6
Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids.

Sanford-Burnham Medical Research Institute
1
Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.

Indiana University School of Medicine
6
Synthesis and characterization of a novel class of protein tyrosine phosphatase inhibitors.

New York University
14
Fatty acids as natural specific inhibitors of the proto-oncogenic protein Shp2.

Xiamen University
50
Using small molecules to target protein phosphatases.

Max Planck Institute of Molecular Physiology
42
Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.

University of California
9
Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2).

Indiana University School of Medicine
30
Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.

Institute For Medical Research
20
Synthesis and phosphatase inhibitory activity of analogs of sulfircin

TBA
29
Discovery and Evaluation of Active Site-Directed, Potent, and Selective Sulfophenyl Acetic Amide-Based Inhibitors for the Laforin Phosphatase.

Purdue University
8
Microascones, Decahydrofluorene-Class Alkaloids from the Marine-Derived Fungus

Chinese Academy of Sciences
7
Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors.

Institute For Medical Research
101
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.

Aristotle University of Thessaloniki
3
Brunsvicamides A-C: sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity.

University of Bonn
31
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors.

Eli Lilly
7
Protein tyrosine phosphatase 1B inhibitors from Morus root bark.

Korea Research Institute of Bioscience and Biotechnology (Kribb)
12
PTP-1B inhibitors: cyclopenta[d][1,2]-oxazine derivatives.

Korea Research Institute of Chemical Technology
7
3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors.

Technische UniversitäT MüNchen
27
Rhodanine derivatives as inhibitors of JSP-1.

Ceptyr
1
Peptidyl aldehydes as slow-binding inhibitors of dual-specificity phosphatases.

The Ohio State University
25
Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets.

Shandong University
33
Inhibition of Low Molecular Weight Protein Tyrosine Phosphatase by an Induced-Fit Mechanism.

Purdue University
19
Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25.

University of Pittsburgh
31
Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.

Tohoku University
36
Highly Potent and Selective

Purdue University
35
Sulfonylated aminothiazoles as new small molecule inhibitors of protein phosphatases.

University of Pittsburgh
116
Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.

Wyeth-Ayerst Research
2
Synthesis and PTP Inhibitory Activity of Illudalic Acid and Its Methyl Ether, with Insights into Selectivity for LAR PTP over Other Tyrosine Phosphatases under Physiologically Relevant Conditions.

University of Utah
6
PTP1B inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-arylbenzo[b]naphtho[2,3-d]furans and 11-arylbenzo[b]naphtho[2,3-d]thiophenes.

Wyeth-Ayerst Research
1
Diversity-Oriented Synthesis for Novel, Selective and Drug-like Inhibitors for a Phosphatase from Mycobacterium Tuberculosis.

Indiana University School of Medicine
13
Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo.

University of Manchester
2
A bromopyrrole-containing diterpene alkaloid from the Okinawan marine sponge Agelas nakamurai activates the insulin pathway in Huh-7 human hepatoma cells by inhibiting protein tyrosine phosphatase 1B.

Tohoku Medical and Pharmaceutical University
3
Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment.

Chinese Academy of Sciences
43
Trk-inhibiting compound

Ono Pharmaceutical
139
Benzimidazol-2-amines as mIDH1 inhibitors

Bayer
45
Apoptosis signal-regulating kinase inhibitors

Gilead Sciences
129
Pyridazine compounds as JAK inhibitors

Portola Pharmaceuticals
3
Substituted pyridine derivatives useful as C-FMS kinase inhibitors

Janssen Pharmaceutica
211
Chromane compounds

Comentis
2
Biochemical characterization of the cellular glycosylphosphatidylinositol-linked membrane type-6 matrix metalloproteinase.

Sanford-Burnham Medical Research Institute
3
Structural Origin of Selectivity in Class II-Selective Histone Deacetylase Inhibitors.

University of Notre Dame
20
Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha.

Dartmouth College
10
Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.

Karo Bio
20
Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.

University of Tennessee At Memphis
16
Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.

University of Tennessee At Memphis